{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:56:34Z","timestamp":1787644594180,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research and Development Fund of Kangda College of Nanjing Medical University","award":["KD2022KYJJZD045"],"award-info":[{"award-number":["KD2022KYJJZD045"]}]},{"name":"Science and Technology Aid Project of Xinjiang Uygur Autonomous Region","award":["2022E02132"],"award-info":[{"award-number":["2022E02132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-025-06371-5","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:33:50Z","timestamp":1745379230000},"page":"2351-2360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical features and outcomes in large granular lymphocyte leukemia\u2009\u2212\u2009associated pure red cell aplasia with STAT3 mutation"],"prefix":"10.1007","volume":"104","author":[{"given":"Xiaoqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"9","key":"6371_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","volume":"129","author":"T Lamy","year":"2017","unstructured":"Lamy T, Moignet A, Loughran TP (2017) LGL leukemia: from pathogenesis to treatment. Blood 129(9):1082\u20131094. https:\/\/doi.org\/10.1182\/blood-2016-08-692590","journal-title":"Blood"},{"issue":"11","key":"6371_CR2","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41375-022-01695-x","volume":"36","author":"G Semenzato","year":"2022","unstructured":"Semenzato G, Teramo A, Calabretto G, Gasparini VR, Zambello R (2022) All that glitters is not LGL leukemia. Leukemia 36(11):2551\u20132557. https:\/\/doi.org\/10.1038\/s41375-022-01695-x","journal-title":"Leukemia"},{"issue":"7","key":"6371_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00277-022-04847-2","volume":"101","author":"X Wu","year":"2022","unstructured":"Wu X, Cheng L, Liu X et al (2022) Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia. Ann Hematol 101(7):1493\u20131498. https:\/\/doi.org\/10.1007\/s00277-022-04847-2","journal-title":"Ann Hematol"},{"issue":"10","key":"6371_CR4","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.12871","volume":"93","author":"N Fujishima","year":"2008","unstructured":"Fujishima N, Sawada K, Hirokawa M et al (2008) Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell Aplasia: a nationwide cohort study in Japan for the PRCA collaborative study group. Haematologica 93(10):1555\u20131559. https:\/\/doi.org\/10.3324\/haematol.12871","journal-title":"Haematologica"},{"issue":"20","key":"6371_CR5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","volume":"366","author":"HL Koskela","year":"2012","unstructured":"Koskela HL, Eldfors S, Ellonen P et al (2012) Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 366(20):1905\u20131913. https:\/\/doi.org\/10.1056\/NEJMoa1114885","journal-title":"N Engl J Med"},{"issue":"10","key":"6371_CR6","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/cells10102800","volume":"10","author":"G Calabretto","year":"2021","unstructured":"Calabretto G, Teramo A, Baril\u00e0 G et al (2021) Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options. Cells 10(10):2800. https:\/\/doi.org\/10.3390\/cells10102800","journal-title":"Cells"},{"issue":"3","key":"6371_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00277-020-03926-6","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Lu X, Chen L et al (2020) Immunosuppressive therapy for elderly-acquired pure red cell Aplasia: cyclosporine A May be more effective. Ann Hematol 99(3):443\u2013449. https:\/\/doi.org\/10.1007\/s00277-020-03926-6","journal-title":"Ann Hematol"},{"issue":"21","key":"6371_CR8","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means","year":"2016","unstructured":"Means RT (2016) Pure red cell aplasia. Blood 128(21):2504\u20132509. https:\/\/doi.org\/10.1182\/blood-2016-05-717140","journal-title":"Blood"},{"issue":"10","key":"6371_CR9","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","volume":"117","author":"T Lamy","year":"2011","unstructured":"Lamy T, Loughran TP (2011) How I treat LGL leukemia. Blood 117(10):2764\u20132774. https:\/\/doi.org\/10.1182\/blood-2010-07-296962","journal-title":"Blood"},{"issue":"1","key":"6371_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ajcp\/aqaa214","volume":"156","author":"P Horna","year":"2021","unstructured":"Horna P, Olteanu H, Jevremovic D et al (2021) Single-Antibody evaluation of T-Cell receptor \u0392 constant chain monotypia by flow cytometry facilitates the diagnosis of T-Cell large granular lymphocytic leukemia. Am J Clin Pathol 156(1):139\u2013148. https:\/\/doi.org\/10.1093\/ajcp\/aqaa214","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"6371_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00277-009-0895-3","volume":"89","author":"YL Kwong","year":"2010","unstructured":"Kwong YL, Au WY, Leung AY et al (2010) T-cell large granular lymphocyte leukemia: an Asian perspective. Ann Hematol 89(4):331\u2013339. https:\/\/doi.org\/10.1007\/s00277-009-0895-3","journal-title":"Ann Hematol"},{"issue":"18","key":"6371_CR12","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.3390\/cancers13184513","volume":"13","author":"V Giudice","year":"2021","unstructured":"Giudice V, D\u2019Addona M, Montuori N, Selleri C (2021) The value of flow cytometry clonality in large granular lymphocyte leukemia. Cancers 13(18):4513. https:\/\/doi.org\/10.3390\/cancers13184513","journal-title":"Cancers"},{"issue":"6","key":"6371_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12185-022-03310-2","volume":"115","author":"F Kawakami","year":"2022","unstructured":"Kawakami F, Kawakami T, Yamane T et al (2022) T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia. Int J Hematol 115(6):816\u2013825. https:\/\/doi.org\/10.1007\/s12185-022-03310-2","journal-title":"Int J Hematol"},{"issue":"37","key":"6371_CR14","doi-asserted-by":"publisher","first-page":"61876","DOI":"10.18632\/oncotarget.18711","volume":"8","author":"A Teramo","year":"2017","unstructured":"Teramo A, Baril\u00e0 G, Calabretto G et al (2017) STAT3 mutation impacts biological and clinical features of T-LGL leukemia. Oncotarget 8(37):61876\u201361889. https:\/\/doi.org\/10.18632\/oncotarget.18711","journal-title":"Oncotarget"},{"issue":"1","key":"6371_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2014.113142","volume":"100","author":"HL Rajala","year":"2015","unstructured":"Rajala HL, Olson T, Clemente MJ et al (2015) The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica 100(1):91\u201399. https:\/\/doi.org\/10.3324\/haematol.2014.113142","journal-title":"Haematologica"},{"issue":"1","key":"6371_CR16","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/s41598-023-33928-z","volume":"13","author":"S Park","year":"2023","unstructured":"Park S, Yun J, Choi SY et al (2023) Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell Aplasia: low mutational burden of STAT3. Sci Rep 13(1):7280. https:\/\/doi.org\/10.1038\/s41598-023-33928-z","journal-title":"Sci Rep"},{"key":"6371_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2017.12.014","volume":"73","author":"M Shi","year":"2018","unstructured":"Shi M, He R, Feldman AL et al (2018) STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia. Hum Pathol 73:74\u201381. https:\/\/doi.org\/10.1016\/j.humpath.2017.12.014","journal-title":"Hum Pathol"},{"issue":"1","key":"6371_CR18","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1038\/s41467-022-31015-x","volume":"13","author":"A Teramo","year":"2022","unstructured":"Teramo A, Binatti A, Ciabatti E et al (2022) Defining TCR\u03b3\u03b4 lymphoproliferative disorders by combined immunophenotypic and molecular evaluation. Nat Commun 13(1):3298. https:\/\/doi.org\/10.1038\/s41467-022-31015-x","journal-title":"Nat Commun"},{"issue":"20","key":"6371_CR19","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.2021013164","volume":"139","author":"H Cheon","year":"2022","unstructured":"Cheon H, Xing JC, Moosic KB et al (2022) Genomic landscape of TCR\u03b1\u03b2 and TCR\u03b3\u03b4 T-large granular lymphocyte leukemia. Blood 139(20):3058\u20133072. https:\/\/doi.org\/10.1182\/blood.2021013164","journal-title":"Blood"},{"issue":"2","key":"6371_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3324\/haematol.2021.279140","volume":"107","author":"D Kim","year":"2022","unstructured":"Kim D, Myllym\u00e4ki M, Kankainen M et al (2022) Somatic STAT3 mutations in CD8\u2009+\u2009T cells of healthy blood donors carrying human T-cell leukemia virus type 2. Haematologica 107(2):550\u2013554. https:\/\/doi.org\/10.3324\/haematol.2021.279140","journal-title":"Haematologica"},{"issue":"3","key":"6371_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.beha.2019.06.006","volume":"32","author":"G Baril\u00e0","year":"2019","unstructured":"Baril\u00e0 G, Calabretto G, Teramo A et al (2019) T cell large granular lymphocyte leukemia and chronic NK lymphocytosis. Best practice & research. Clin Haematol 32(3):207\u2013216. https:\/\/doi.org\/10.1016\/j.beha.2019.06.006","journal-title":"Clin Haematol"},{"issue":"20","key":"6371_CR22","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","volume":"2","author":"T Kawakami","year":"2018","unstructured":"Kawakami T, Sekiguchi N, Kobayashi J et al (2018) Frequent STAT3 mutations in CD8\u2009+\u2009T cells from patients with pure red cell aplasia. Blood Adv 2(20):2704\u20132712. https:\/\/doi.org\/10.1182\/bloodadvances.2018022723","journal-title":"Blood Adv"},{"issue":"4","key":"6371_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/leu.2014.298","volume":"29","author":"TP Loughran","year":"2015","unstructured":"Loughran TP, Zickl L, Olson TL et al (2015) Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern cooperative oncology group (E5998). Leukemia 29(4):886\u2013894. https:\/\/doi.org\/10.1038\/leu.2014.298","journal-title":"Leukemia"},{"issue":"2","key":"6371_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","volume":"12","author":"D Bhattacharya","year":"2022","unstructured":"Bhattacharya D, Teramo A, Gasparini VR et al (2022) Identification of novel STAT5B mutations and characterization of TCR\u03b2 signatures in CD4\u2009+\u2009T-cell large granular lymphocyte leukemia. Blood cancer J 12(2):31. https:\/\/doi.org\/10.1038\/s41408-022-00630-8","journal-title":"Blood cancer J"},{"issue":"4","key":"6371_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","volume":"34","author":"G Baril\u00e0","year":"2020","unstructured":"Baril\u00e0 G, Teramo A, Calabretto G et al (2020) Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients. Leukemia 34(4):1116\u20131124. https:\/\/doi.org\/10.1038\/s41375-019-0644-0","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06371-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06371-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06371-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:14:20Z","timestamp":1746414860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06371-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6371"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06371-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was approved by the Ethics Committee of Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University; and the approval file number was 2020-SR-013. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}